AR046770A1 - Derivados bencimidazol 5- o 6-substituidos como inhibidores de la replicacion del virus sincitial respiratorio - Google Patents
Derivados bencimidazol 5- o 6-substituidos como inhibidores de la replicacion del virus sincitial respiratorioInfo
- Publication number
- AR046770A1 AR046770A1 ARP040104808A ARP040104808A AR046770A1 AR 046770 A1 AR046770 A1 AR 046770A1 AR P040104808 A ARP040104808 A AR P040104808A AR P040104808 A ARP040104808 A AR P040104808A AR 046770 A1 AR046770 A1 AR 046770A1
- Authority
- AR
- Argentina
- Prior art keywords
- het
- alkyl
- hydrogen
- replication
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La presente se refiere a derivados de bencimidazol 5- o 6-sustituidos que tienen actividad inhibidora sobre la replicación sobre el virus sincitial respiratorio y que tienen la formula (1), profármacos, N-oxido, sal de adición, amina cuaternaria, complejo metálico o forma estereoquímicamente isomérica del mismo donde Q es Ar2, R6a, pirrolidinilo substituido con R6, piperidinilo substituido con R6 u homopiperidinilo con R6; G es un enlace directo o un alcanodiilo C1-10 opcionalmente sustituido; R1 es Ar1 o un heterociclo monocíclico o bicíclico; uno de R2a y R2b es cianoalquilo C1-6, cianoalquenilo C2-6, Ar3-alquilo C1-6, Het-alquilo C1-6, N(R8aR8b)alquilo C1-6, Ar3-alquenilo C2-6, Het-alquenilo C2-6, Ar3-aminoalquilo C1-6, Het- aminoalquilo C1-6, Ar3-tioalquilo C1-6, Het-tioalquilo C1-6, Ar3-sulfonilalquilo C1-6, Het-sulfonilalquilo C1-6, Ar3-aminocarbonilo, Het-aminocarbonilo, Ar3(CH2)naminocarbonilo, Het-(CH2)naminocarbonilo, Ar3-carbonilamino, Het-carbonilamino, Ar3(CH2)ncarbonilamino, Y otro de R2a y R2b es hidrógeno; en el caso de que R2a sea hidrógeno, entonces R3 es hidrógeno; en el caso de que R2b sea hidrógeno, entonces R3 es hidrógeno o alquilo C1-6. Se refiere además a su preparación y a las composiciones que los comprenden así como también a su uso como medicamento.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03104806 | 2003-12-18 | ||
US56686704P | 2004-04-30 | 2004-04-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR046770A1 true AR046770A1 (es) | 2005-12-21 |
Family
ID=43646156
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP040104808A AR046770A1 (es) | 2003-12-18 | 2004-12-20 | Derivados bencimidazol 5- o 6-substituidos como inhibidores de la replicacion del virus sincitial respiratorio |
Country Status (19)
Country | Link |
---|---|
US (2) | US20070093502A1 (es) |
EP (1) | EP1697347B1 (es) |
JP (1) | JP2007514719A (es) |
KR (1) | KR101123055B1 (es) |
CN (1) | CN1914196B (es) |
AR (1) | AR046770A1 (es) |
AT (1) | ATE499361T1 (es) |
AU (1) | AU2004298459B2 (es) |
BR (1) | BRPI0417273A (es) |
CA (1) | CA2548793A1 (es) |
DE (1) | DE602004031555D1 (es) |
DK (1) | DK1697347T3 (es) |
HR (1) | HRP20110313T1 (es) |
MX (1) | MXPA06007111A (es) |
MY (1) | MY142783A (es) |
RU (1) | RU2369606C2 (es) |
SI (1) | SI1697347T1 (es) |
TW (1) | TWI382981B (es) |
WO (1) | WO2005058874A1 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2612264C (en) * | 2005-06-20 | 2014-09-23 | Tibotec Pharmaceuticals Ltd. | Heterocyclylaminoalkyl substituted benzimidazoles |
WO2013056070A2 (en) | 2011-10-14 | 2013-04-18 | Ambit Biosciences Corporation | Heterocyclic compounds and methods of use thereof |
TW201825465A (zh) | 2016-09-23 | 2018-07-16 | 美商基利科學股份有限公司 | 磷脂醯肌醇3-激酶抑制劑 |
TW201813963A (zh) | 2016-09-23 | 2018-04-16 | 美商基利科學股份有限公司 | 磷脂醯肌醇3-激酶抑制劑 |
TW201815787A (zh) | 2016-09-23 | 2018-05-01 | 美商基利科學股份有限公司 | 磷脂醯肌醇3-激酶抑制劑 |
NZ763766A (en) | 2017-03-20 | 2023-07-28 | Novo Nordisk Healthcare Ag | Pyrrolopyrrole compositions as pyruvate kinase (pkr) activators |
US10793551B2 (en) | 2017-10-19 | 2020-10-06 | Effector Therapeutics Inc. | Benzimidazole-indole inhibitors of Mnk1 and Mnk2 |
EP3852791B1 (en) | 2018-09-19 | 2024-07-03 | Novo Nordisk Health Care AG | Activating pyruvate kinase r |
BR112021005188A2 (pt) | 2018-09-19 | 2021-06-08 | Forma Therapeutics, Inc. | tratamento de anemia falciforme com um composto de ativação de piruvato cinase r |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4025621A (en) * | 1975-01-09 | 1977-05-24 | Purdy Clarence L | Method of curing and providing immunity from viral infections |
CA1140119A (en) | 1978-04-03 | 1983-01-25 | Joseph Torremans | N-heterocyclyl-4-piperidinamines |
US4556660A (en) | 1982-07-12 | 1985-12-03 | Janssen Pharmaceutica N.V. | N-(Bicyclic heterocyclyl)-4-piperidinamines |
US4634704A (en) | 1983-10-06 | 1987-01-06 | Janssen Pharmaceutica, N.V. | Anti-allergic five membered heterocyclic ring containing N-(bicyclic heterocycyl)-4-piperidinamines |
KR100190299B1 (ko) | 1990-07-19 | 1999-06-01 | 디르크 반테 | 신규한 옥사졸릴 유도체 |
NZ515418A (en) * | 1999-06-28 | 2003-11-28 | Janssen Pharmaceutica Nv | Respiratory syncytial virus replication inhibitors |
EA004746B1 (ru) * | 1999-06-28 | 2004-08-26 | Янссен Фармацевтика Н.В. | Производные бензимидазола и имидазопиридина в качестве ингибиторов репликации респираторно-синцитиального вируса |
EP1196409B1 (en) * | 1999-06-28 | 2004-02-04 | Janssen Pharmaceutica N.V. | Respiratory syncytial virus replication inhibitors |
US20040157866A1 (en) * | 2001-04-30 | 2004-08-12 | Hisashi Takasugi | Amide compounds |
US7030150B2 (en) * | 2001-05-11 | 2006-04-18 | Trimeris, Inc. | Benzimidazole compounds and antiviral uses thereof |
FR2833948B1 (fr) * | 2001-12-21 | 2004-02-06 | Sod Conseils Rech Applic | Nouveaux derives de benzimidazole et leur utilisation en tant que medicament |
-
2004
- 2004-12-20 BR BRPI0417273-6A patent/BRPI0417273A/pt not_active Application Discontinuation
- 2004-12-20 DE DE602004031555T patent/DE602004031555D1/de active Active
- 2004-12-20 KR KR1020067014248A patent/KR101123055B1/ko not_active IP Right Cessation
- 2004-12-20 MX MXPA06007111A patent/MXPA06007111A/es active IP Right Grant
- 2004-12-20 SI SI200431657T patent/SI1697347T1/sl unknown
- 2004-12-20 DK DK04804954.8T patent/DK1697347T3/da active
- 2004-12-20 AU AU2004298459A patent/AU2004298459B2/en not_active Ceased
- 2004-12-20 WO PCT/EP2004/053618 patent/WO2005058874A1/en active Application Filing
- 2004-12-20 TW TW093139735A patent/TWI382981B/zh not_active IP Right Cessation
- 2004-12-20 JP JP2006544465A patent/JP2007514719A/ja active Pending
- 2004-12-20 AR ARP040104808A patent/AR046770A1/es not_active Application Discontinuation
- 2004-12-20 EP EP04804954A patent/EP1697347B1/en active Active
- 2004-12-20 MY MYPI20045258A patent/MY142783A/en unknown
- 2004-12-20 CN CN2004800416543A patent/CN1914196B/zh active Active
- 2004-12-20 RU RU2006125727/04A patent/RU2369606C2/ru not_active IP Right Cessation
- 2004-12-20 AT AT04804954T patent/ATE499361T1/de not_active IP Right Cessation
- 2004-12-20 CA CA002548793A patent/CA2548793A1/en not_active Abandoned
- 2004-12-20 US US10/596,521 patent/US20070093502A1/en not_active Abandoned
-
2008
- 2008-10-17 US US12/253,450 patent/US8278455B2/en active Active
-
2011
- 2011-04-29 HR HR20110313T patent/HRP20110313T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
CA2548793A1 (en) | 2005-06-30 |
AU2004298459B2 (en) | 2011-03-17 |
EP1697347A1 (en) | 2006-09-06 |
ATE499361T1 (de) | 2011-03-15 |
RU2369606C2 (ru) | 2009-10-10 |
CN1914196B (zh) | 2012-01-25 |
EP1697347B1 (en) | 2011-02-23 |
US8278455B2 (en) | 2012-10-02 |
KR101123055B1 (ko) | 2012-04-12 |
WO2005058874A1 (en) | 2005-06-30 |
HRP20110313T1 (hr) | 2011-05-31 |
AU2004298459A1 (en) | 2005-06-30 |
CN1914196A (zh) | 2007-02-14 |
DE602004031555D1 (de) | 2011-04-07 |
TWI382981B (zh) | 2013-01-21 |
SI1697347T1 (sl) | 2011-06-30 |
RU2006125727A (ru) | 2008-01-27 |
MY142783A (en) | 2010-12-31 |
JP2007514719A (ja) | 2007-06-07 |
US20090062278A1 (en) | 2009-03-05 |
US20070093502A1 (en) | 2007-04-26 |
TW200531970A (en) | 2005-10-01 |
DK1697347T3 (da) | 2011-06-06 |
MXPA06007111A (es) | 2006-08-23 |
KR20060127047A (ko) | 2006-12-11 |
BRPI0417273A (pt) | 2007-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12016500553B1 (en) | Substituted quinolizine derivatives useful as hiv integrase inhibitors | |
TR201810944T4 (tr) | Fgfr4 inhibitörleri olarak halka-füzyonlu bisiklik piridil türevleri. | |
MX2015012432A (es) | Inhibidores piridinicos de la cinasa cdk9. | |
IS8503A (is) | Azatvíhringja heteróhringir sem kannabínóníð-viðtakastillar | |
AR035991A1 (es) | Derivados de benzimidazoles e imidazopiridinas, un procedimiento para su preparacion, composiciones farmaceuticas, un procedimiento para su preparacion, y un medicamento utiles como inhibidores de la replicacion del virus sincitial respiratorio | |
MX2007003546A (es) | Derivados de indozolona como inhibidores de 11-beta- hidroxiesteroide-deshidrogenasa. | |
AR046771A1 (es) | Derivados piperidina-amino-bencimidazol como inhibidores de la replicacion del virus sincitial respiratorio | |
BR112015007698A2 (pt) | Composto, composição farmacêutica, e, uso de um composto | |
MX2009012613A (es) | Tiazoles substituidos por heteroarilo y su uso como agentes antivirales. | |
TW200626154A (en) | Heterocyclic derivatives and their use as therapeutic agents | |
ECSP109903A (es) | Derivados de pirazinona y su uso en el tratamiento de enfermedades pulmonares | |
BRPI0507312A (pt) | derivados de quinolina para uso como inibidores micobacterianos | |
TW200626153A (en) | Heterocyclic derivatives and their use as therapeutic agents | |
TW200626148A (en) | Heterocyclic derivatives and their use as therapeutic agents | |
TW200626592A (en) | Heterocyclic derivatives and their use as therapeutic agents | |
TW200626139A (en) | Heterocyclic derivatives and their use as therapeutic agents | |
TW200626155A (en) | Heterocyclic derivatives and their use as therapeutic agents | |
PH12016500911A1 (en) | 2,6-substituted purine derivatives and their use in the treatment of proliferative disorders | |
AR046959A1 (es) | Morfolinilo que contiene bencimidazoles como inhibidores de la replicacion del virus sincitial respiratorio | |
AR041545A1 (es) | Derivados sustituidos de 1,4-di-piperidin-4 il-piperazina y su uso como antagonistas de neuroquininas | |
MA32544B1 (fr) | Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique | |
ECSP15035530A (es) | Compuestos tetracíclicos sustituidos con heterociclo y métodos de uso de los mismos para el tratamiento de enfermedades víricas | |
IL200469A0 (en) | Benzimidazole derivatives | |
MY173573A (en) | Pyridin-4-yl derivatives | |
MY183039A (en) | Pyridin-2-yl derivatives as immunomodulating agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |